Paper4810941
Antibacterial activity in serum and urine as a therapeutic guide in bacterial infections.
Klastersky J and 3 others. J Infect Dis, 1974. Cited by 264 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Antibacterial activity in serum and urine as a therapeutic guide in bacterial infections. Papers, record 4810941. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/4810941
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Antibacterial activity in serum and urine as a therapeutic guide in bacterial infections.
- PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Anti-Bacterial Agents | Major topic |
| Bacterial Infections | Major topic |
| Blood Bactericidal Activity | Major topic |
| Carbenicillin | |
| Cephalexin | |
| Cephalothin | |
| Doxycycline | |
| Drug Therapy, Combination | |
| Gentamicins | |
| Humans | |
| Respiratory Tract Infections | |
| Sepsis | |
| Urinary Tract Infections | |
| Wound Infection |
Source PubMed
Cited by86
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 264 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 34,435,316 | Potential Antibiotics for the Treatment of Neonatal Sepsis Caused by Multidrug-Resistant Bacteria. | Paediatr Drugs | 2021 | https://conductscience.org/library/papers/34435316 | PubMed |
| 23,960,738 | Once versus individualized multiple daily dosing of aminoglycosides in critically ill patients. | Saudi Pharm J | 2011 | https://conductscience.org/library/papers/23960738 | PubMed |
| 22,162,703 | Polymyxin Combination Therapy and the Use of Serum Bactericidal Titers in the Management of KPC-Producing Klebsiella pneumoniae Infections: A Report of 3 Cases. | Case Rep Med | 2011 | https://conductscience.org/library/papers/22162703 | PubMed |
| 11,353,641 | Antibacterial properties of gemifloxacin and trovafloxacin in urine ex vivo: phase I study. | Antimicrob Agents Chemother | 2001 | https://conductscience.org/library/papers/11353641 | PubMed |
| 11,083,664 | Levofloxacin pharmacokinetics and serum bactericidal activities against five enterobacterial species. | Antimicrob Agents Chemother | 2000 | https://conductscience.org/library/papers/11083664 | PubMed |
| 10,554,046 | Basis of anti-infective therapy: pharmacokinetic-pharmacodynamic criteria and methodology for dual dosage individualisation. | Clin Pharmacokinet | 1999 | https://conductscience.org/library/papers/10554046 | PubMed |
| 10,146,940 | Pharmacoeconomics of intravenous drug administration. | Pharmacoeconomics | 1992 | https://conductscience.org/library/papers/10146940 | PubMed |
| 10,049,277 | Optimizing aminoglycoside therapy for nosocomial pneumonia caused by gram-negative bacteria. | Antimicrob Agents Chemother | 1999 | https://conductscience.org/library/papers/10049277 | PubMed |
| 9,661,031 | Dosing of aminoglycosides to rapidly attain pharmacodynamic goals and hasten therapeutic response by using individualized pharmacokinetic monitoring of patients with pneumonia caused by gram-negative organisms. | Antimicrob Agents Chemother | 1998 | https://conductscience.org/library/papers/9661031 | PubMed |
| 9,174,206 | Pharmacodynamic effects of amoxicillin versus cefotaxime against penicillin-susceptible and penicillin-resistant pneumococcal strains: a phase I study. | Antimicrob Agents Chemother | 1997 | https://conductscience.org/library/papers/9174206 | PubMed |
| 9,145,846 | Suspicion of quinolone active metabolite following discrepancy between predicted and experimental urine bactericidal activities. | Antimicrob Agents Chemother | 1997 | https://conductscience.org/library/papers/9145846 | PubMed |
| 8,851,610 | Pharmacokinetics of sparfloxacin and serum bactericidal activity against pneumococci. | Antimicrob Agents Chemother | 1996 | https://conductscience.org/library/papers/8851610 | PubMed |
| 8,834,888 | Single-dose rufloxacin versus 3-day norfloxacin treatment of uncomplicated cystitis: clinical evaluation and pharmacodynamic considerations. | Antimicrob Agents Chemother | 1996 | https://conductscience.org/library/papers/8834888 | PubMed |
| 8,787,889 | Serum bactericidal activities and comparative pharmacokinetics of meropenem and imipenem-cilastatin. | Antimicrob Agents Chemother | 1996 | https://conductscience.org/library/papers/8787889 | PubMed |
| 8,787,872 | Ex vivo antibacterial properties of rufloxacin compared with those of norfloxacin in a study with healthy volunteers. | Antimicrob Agents Chemother | 1996 | https://conductscience.org/library/papers/8787872 | PubMed |
| 8,723,449 | Monotherapy with meropenem versus combination therapy with ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer. The International Antimicrobial Therapy Cooperative Group of the European Organization for Research and Treatment of Cancer and the Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto Infection Program. | Antimicrob Agents Chemother | 1996 | https://conductscience.org/library/papers/8723449 | PubMed |
| 8,239,592 | Comparative pharmacokinetics and serum bactericidal activities of SCE-2787 and ceftazidime. | Antimicrob Agents Chemother | 1993 | https://conductscience.org/library/papers/8239592 | PubMed |
| 8,193,880 | Double beta-lactam regimen compared to an aminoglycoside/beta-lactam regimen as empiric antibiotic therapy for febrile granulocytopenic cancer patients. | Support Care Cancer | 1993 | https://conductscience.org/library/papers/8193880 | PubMed |
| 7,518,762 | Comparative pharmacokinetics of the new oral cephalosporins. | Drugs | 1994 | https://conductscience.org/library/papers/7518762 | PubMed |
| 7,399,715 | Basis for an adequate dosage of aminoglycoside antibiotics. | Infection | 1980 | https://conductscience.org/library/papers/7399715 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/4810941
GET https://conductscience.org/api/papers/v1/4810941/cited_by?page=2